GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 134 filers reported holding GENOMIC HEALTH INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,216,000 | -62.3% | 32,676 | -67.6% | 0.00% | -66.7% |
Q2 2019 | $5,873,000 | -40.0% | 100,960 | -27.7% | 0.01% | -40.0% |
Q1 2019 | $9,781,000 | +80.8% | 139,622 | +66.3% | 0.01% | +66.7% |
Q4 2018 | $5,409,000 | -15.2% | 83,973 | -7.5% | 0.01% | 0.0% |
Q3 2018 | $6,376,000 | +66.0% | 90,806 | +19.1% | 0.01% | +50.0% |
Q2 2018 | $3,841,000 | -40.8% | 76,217 | -63.2% | 0.00% | -42.9% |
Q1 2018 | $6,488,000 | -2.5% | 207,340 | +6.6% | 0.01% | 0.0% |
Q4 2017 | $6,652,000 | +16.3% | 194,503 | +9.1% | 0.01% | +16.7% |
Q3 2017 | $5,721,000 | +38.1% | 178,286 | +40.1% | 0.01% | +50.0% |
Q2 2017 | $4,143,000 | +4.3% | 127,294 | +0.9% | 0.00% | 0.0% |
Q1 2017 | $3,974,000 | +6.3% | 126,202 | -0.8% | 0.00% | 0.0% |
Q4 2016 | $3,738,000 | +320.5% | 127,196 | +314.0% | 0.00% | +300.0% |
Q3 2016 | $889,000 | +21.0% | 30,724 | +8.3% | 0.00% | 0.0% |
Q2 2016 | $735,000 | – | 28,369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |